147 related articles for article (PubMed ID: 21618708)
1. Upregulation of LAPTM4B-35 promotes malignant transformation and tumorigenesis in L02 human liver cell line.
Li L; Shan Y; Yang H; Zhang S; Lin M; Zhu P; Chen XY; Yi J; McNutt MA; Shao GZ; Zhou RL
Anat Rec (Hoboken); 2011 Jul; 294(7):1135-42. PubMed ID: 21618708
[TBL] [Abstract][Full Text] [Related]
2. LAPTM4B: a novel cancer-associated gene motivates multidrug resistance through efflux and activating PI3K/AKT signaling.
Li L; Wei XH; Pan YP; Li HC; Yang H; He QH; Pang Y; Shan Y; Xiong FX; Shao GZ; Zhou RL
Oncogene; 2010 Oct; 29(43):5785-95. PubMed ID: 20711237
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of LAPTM4B-35 promotes growth and metastasis of hepatocellular carcinoma in vitro and in vivo.
Yang H; Xiong F; Wei X; Yang Y; McNutt MA; Zhou R
Cancer Lett; 2010 Aug; 294(2):236-44. PubMed ID: 20202745
[TBL] [Abstract][Full Text] [Related]
4. LAPTM4B-35, a novel tetratransmembrane protein and its PPRP motif play critical roles in proliferation and metastatic potential of hepatocellular carcinoma cells.
Liu X; Xiong F; Wei X; Yang H; Zhou R
Cancer Sci; 2009 Dec; 100(12):2335-40. PubMed ID: 19843073
[TBL] [Abstract][Full Text] [Related]
5. Eriocalyxin B induces apoptosis in lymphoma cells through multiple cellular signaling pathways.
Zhang YW; Jiang XX; Chen QS; Shi WY; Wang L; Sun HD; Shen ZX; Chen Z; Chen SJ; Zhao WL
Exp Hematol; 2010 Mar; 38(3):191-201. PubMed ID: 20045442
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning and characterization of LAPTM4B, a novel gene upregulated in hepatocellular carcinoma.
Shao GZ; Zhou RL; Zhang QY; Zhang Y; Liu JJ; Rui JA; Wei X; Ye DX
Oncogene; 2003 Aug; 22(32):5060-9. PubMed ID: 12902989
[TBL] [Abstract][Full Text] [Related]
7. P16 reactivation induces anoikis and exhibits antitumour potency by downregulating Akt/survivin signalling in hepatocellular carcinoma cells.
Hu H; Li Z; Chen J; Wang D; Ma J; Wang W; Li J; Wu H; Li L; Wu M; Qian Q; Chen J; Su C
Gut; 2011 May; 60(5):710-21. PubMed ID: 20971978
[TBL] [Abstract][Full Text] [Related]
8. AP4 positively regulates LAPTM4B to promote hepatocellular carcinoma growth and metastasis, while reducing chemotherapy sensitivity.
Meng Y; Wang L; Xu J; Zhang Q
Mol Oncol; 2018 Mar; 12(3):373-390. PubMed ID: 29337428
[TBL] [Abstract][Full Text] [Related]
9. Enhanced apoptosis following treatment with TRA-8 anti-human DR5 monoclonal antibody and overexpression of exogenous Bax in human glioma cells.
Kaliberov S; Stackhouse MA; Kaliberova L; Zhou T; Buchsbaum DJ
Gene Ther; 2004 Apr; 11(8):658-67. PubMed ID: 14973547
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.
Zhao J; Dong L; Lu B; Wu G; Xu D; Chen J; Li K; Tong X; Dai J; Yao S; Wu M; Guo Y
Gastroenterology; 2008 Sep; 135(3):956-68. PubMed ID: 18555021
[TBL] [Abstract][Full Text] [Related]
11. Leptin induces proliferation and anti-apoptosis in human hepatocarcinoma cells by up-regulating cyclin D1 and down-regulating Bax via a Janus kinase 2-linked pathway.
Chen C; Chang YC; Liu CL; Liu TP; Chang KJ; Guo IC
Endocr Relat Cancer; 2007 Jun; 14(2):513-29. PubMed ID: 17639064
[TBL] [Abstract][Full Text] [Related]
12. The proto-oncoprotein c-Fos negatively regulates hepatocellular tumorigenesis.
Mikula M; Gotzmann J; Fischer AN; Wolschek MF; Thallinger C; Schulte-Hermann R; Beug H; Mikulits W
Oncogene; 2003 Oct; 22(43):6725-38. PubMed ID: 14555986
[TBL] [Abstract][Full Text] [Related]
13. Adenovirus vector expressing mda-7 selectively kills hepatocellular carcinoma cell line Hep3B.
Xue XB; Chen K; Wang CJ; Zheng JW; Yu Y; Peng ZH; Wu ZD
Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):509-14. PubMed ID: 18842498
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific expression of Bax delivered by an adenoviral vector induces apoptosis in LNCaP prostate cancer cells.
Lowe SL; Rubinchik S; Honda T; McDonnell TJ; Dong JY; Norris JS
Gene Ther; 2001 Sep; 8(18):1363-71. PubMed ID: 11571575
[TBL] [Abstract][Full Text] [Related]
15. Targeting beta2-microglobulin mediated signaling as a novel therapeutic approach for human renal cell carcinoma.
Nomura T; Huang WC; Seo S; Zhau HE; Mimata H; Chung LW
J Urol; 2007 Jul; 178(1):292-300. PubMed ID: 17499801
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of LAPTM4B promotes growth of gallbladder carcinoma cells in vitro.
Zhou L; He XD; Yu JC; Zhou RL; Yang H; Qu Q; Rui JA
Am J Surg; 2010 Apr; 199(4):515-21. PubMed ID: 19954766
[TBL] [Abstract][Full Text] [Related]
17. The human LAPTM4b transcript is upregulated in various types of solid tumours and seems to play a dual functional role during tumour progression.
Kasper G; Vogel A; Klaman I; Gröne J; Petersen I; Weber B; Castaños-Vélez E; Staub E; Mennerich D
Cancer Lett; 2005 Jun; 224(1):93-103. PubMed ID: 15911104
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-alpha inhibits the intrinsic pathway of c-Myc-induced apoptosis through activation of nuclear factor-kappaB in murine hepatocellular carcinomas.
Cavin LG; Wang F; Factor VM; Kaur S; Venkatraman M; Thorgeirsson SS; Arsura M
Mol Cancer Res; 2005 Jul; 3(7):403-12. PubMed ID: 16046551
[TBL] [Abstract][Full Text] [Related]
19. [Mda-7-carrying replication-defective adenovirus selectively kills hepatocellular carcinoma cells by facilitating release of proapoptotic protein from mitochondria].
Wang CJ; Peng ZH; Zheng JW; Chen K; Hu HY; Ji WW; Yu Y; Xue XB
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):649-53. PubMed ID: 19173903
[TBL] [Abstract][Full Text] [Related]
20. LAPTM4B-35 is a novel prognostic factor of hepatocellular carcinoma.
Yang H; Xiong F; Qi R; Liu Z; Lin M; Rui J; Su J; Zhou R
J Surg Oncol; 2010 Apr; 101(5):363-9. PubMed ID: 20358632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
